Yaupon Therapeutics, Inc Email Format

Biotechnology ResearchPennsylvania, United States2-10 Employees

Yaupon Therapeutics, Inc. is a privately held specialty pharmaceutical company based in Radnor, Pennsylvania. It develops small molecule medicines licensed from underserved academic laboratories, advancing early-stage discoveries into proprietary candidates.

The lead candidate, Clearazide, is a topical formulation of nitrogen mustard that is being evaluated in a pivotal Phase II/III trial under an FDA Special Protocol Assessment for early-stage cutaneous T-cell lymphoma, mycosis fungoides. The FDA has granted it fast-track designation and orphan drug status. The company operates with a small team and concentrates on a topical therapy for CTCL‑MF.

Sign up for free to view info

Company overview Employee directory